TiGenix is a venture backed, private biomedical company based in Belgium. It was founded in 2000 as a spin-off of the Universities of Leuven and Ghent. The company operates at the cutting edge of regenerative medicine and focuses on the development of innovative local treatments for damaged and osteoarthritic joints.